» Articles » PMID: 37051407

Determinants of Blood Culture Use in Critically Ill Children: A Multicenter Qualitative Study

Overview
Date 2023 Apr 13
PMID 37051407
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: We conducted semistructured interviews of clinicians (M.D., D.O., R.N., N.P., P.A.) from 6 PICUs who had participated in a quality improvement collaborative about blood culture practices. We developed interview questions by combining elements of the Consolidated Framework for Implementation Research and behavioral economics. We conducted telephone interviews, open-coded the transcripts, and used modified content analysis to determine key themes and mapped themes to elements of Consolidated Framework for Implementation Research and behavioral economics.

Results: We reached thematic saturation in 24 interviews. Seven core themes emerged across 3 Consolidated Framework for Implementation Research domains: individual characteristics [personal belief in the importance of blood cultures, the perception that blood cultures are a low-risk test]; inner setting [adherence to site-specific usual practices, site-specific overall approach to PICU care (collaborative versus hierarchical), influence of non-PICU clinicians on blood culture decisions]; and outer setting [patient-specific risk factors, sepsis guidelines]. In addition, outcome bias, default bias, and loss aversion emerged as salient behavioral economics concepts.

Conclusions: Determinants of blood culture use include individual clinician characteristics, inner setting, and outer setting, as well as default bias, outcome bias, and loss aversion. These determinants will now inform the development of candidate strategies to optimize culture practices.

Citing Articles

Diagnostic stewardship for blood cultures in the pediatric intensive care unit: lessons in implementation from the BrighT STAR Collaborative.

Woods-Hill C, Koontz D, Xie A, Colantuoni E, Sick-Samuels A, Miller M Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e148.

PMID: 39346668 PMC: 11428017. DOI: 10.1017/ash.2024.416.

References
1.
Shehab N, Lovegrove M, Geller A, Rose K, Weidle N, Budnitz D . US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. JAMA. 2016; 316(20):2115-2125. PMC: 6490178. DOI: 10.1001/jama.2016.16201. View

2.
Wang S, Groene O . The effectiveness of behavioral economics-informed interventions on physician behavioral change: A systematic literature review. PLoS One. 2020; 15(6):e0234149. PMC: 7272062. DOI: 10.1371/journal.pone.0234149. View

3.
Alahmadi Y, Aldeyab M, McElnay J, Scott M, Darwish Elhajji F, Magee F . Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect. 2011; 77(3):233-6. DOI: 10.1016/j.jhin.2010.09.033. View

4.
Morgan D, Brownlee S, Leppin A, Kressin N, Dhruva S, Levin L . Setting a research agenda for medical overuse. BMJ. 2015; 351:h4534. PMC: 4563792. DOI: 10.1136/bmj.h4534. View

5.
Woods-Hill C, Lee L, Xie A, King A, Voskertchian A, Klaus S . Dissemination of a Novel Framework to Improve Blood Culture Use in Pediatric Critical Care. Pediatr Qual Saf. 2018; 3(5):e112. PMC: 6221585. DOI: 10.1097/pq9.0000000000000112. View